Analytical Methods for Bioanalysis

Robust resources at the ready.

Abacavir / Darunavir / Etravirine / Lamivudine / Nevirapine / Saquinavir / Stavudine / Zidovudine – combo method

Amprenavir

Amprenavir / Ritonavir – combo method

Azithromycin

Emtricitabine

Emtricitabine / Tenofovir – combo method

Lopinavir / Ritonavir – combo method

Proprietary methods approved for use in COVID-19 trials:
Hydroxychloroquine
 

Maraviroc

Raltegravir

Ribavirin

Rilpivirine

Ritonavir

Tenofovir
 

 




COVID-19

From preclinical research through clinical development, we’re here to help you at every stage of the continuum to deliver accurate, on-time results and advance your program. To meet your program’s requirements, our GLP, nonproprietary methods have been developed according to FDA Crystal City and current regulatory guidelines. With Covance as your partner, you’ll benefit from our expert scientific team and state-of-the-art technologies to support your DDI, concomitant drugs and generics studies.

For your convenience, we’ve organized our nonproprietary bioanalytical methods into two categories: single analyte methods and multi-analyte methods, accessible in the PDFs below. These lists now include therapeutic area and disease.